|
|
|
Volumn 24, Issue 2, 2001, Pages 222-
|
|
About the article: "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis" by Jacobs LD et al.;Premiers épisodes cliniques de démyélinisation: une nouvelle prise en charge thérapeutique?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA INTERFERON;
CORTICOSTEROID;
IMMUNOLOGICAL ADJUVANT;
PLACEBO;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
DRUG COMBINATION;
FOLLOW UP;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MULTIPLE SCLEROSIS;
MYELOOPTIC NEUROPATHY;
OPTIC NERVE DISEASE;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
TIME;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, ORAL;
ADRENAL CORTEX HORMONES;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
INJECTIONS, INTRAVENOUS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
NEUROMYELITIS OPTICA;
OPTIC NERVE DISEASES;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
TIME FACTORS;
|
|
EID: 0035260548
PISSN: 01815512
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
